We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Statistics enable/disable

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name	econda
Purpose	Statistics

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Habibollah Arefian, PhD (Dr. rer. nat.)

Position:

Researcher

Dr. Habibollah Arefian is a health economist and an epidemiologist with wide experience in health economic evaluations, especially in health economic modelling and evidence synthesis. His health economic research explores the cost effectiveness analyses, the development and specification of advanced budget impact models, as well as social cost value analyses.

Prior to his arrival at the DKFZ, Habibollah worked as researcher at the Jena University Hospital (UKJ) in Germany. His work at the UKJ included a variety of research projects, such as health economic evaluation of interventional and non-interventional studies, health economic cost-effectiveness modelling, estimation of extra length of stay attributable to healthcare-associated infections, systematic reviews and meta-analyses.

He has a PhD (Dr. rer. nat.) from the Friedrich-Schiller University of Jena in Germany and a master's degree in Epidemiology from the Charité - University Medicine Berlin, Germany.

Selected Publications

M. Sieg, M. Hartmann, U. Settmacher, H. Arefian:
Comparative cost-effectiveness of cabozantinib as second-line therapy for patients with advanced hepatocellular carcinoma in Germany and the United States.
BMC Gastroenterology, (2020) 20(1), 120.
DOI: 10.1186/s12876-020-01241-y

H. Arefian, S. Heublein, A. Scherag, F.M. Brunkhorst, M.Z. Younis, O. Moerer, D. Fischer, M. Hartmann:
Hospital-related cost of sepsis: A systematic review.
Journal of Infection, (2017) 74(2) 107-117.
DOI: 10.1016/j.jinf.2016.11.006

H. Arefian, S. Hagel, S. Heublein, F. Rissner, A. Scherag, F.M. Brunkhorst, R.J. Baldessarini, M. Hartmann:
Extra length of stay and costs because of health care-associated infections at a German university hospital.
American Journal of Infection Control, (2016) 44(2), 160-166.
DOI: 10.1016/j.ajic.2015.09.005